MedPath

Comparison of dexmedetomidine and clonidine in caudal block in paediatric patients posted for infra umbilical surgeries.

Phase 2
Not yet recruiting
Conditions
Disorder of urinary system, unspecified,
Registration Number
CTRI/2024/01/061191
Lead Sponsor
Acharya Vinobha Bhave Rural Hospital
Brief Summary

Caudal analgesia isan accepted and popular method of providing intra- and post-operative analgesiafor infra abdominal surgeries in children. Bupivacaine is the most commonlyused local anaesthetic for this purpose. The limitation of bupivacaine is theshort duration of action, about four to six hours, when administered as a‘single shot technique’. Several adjuncts such as opioids, ketamine, midazolam,clonidine and neostigmine have been used with bupivacaine to prolong its action(de Beer and Thomas, 2003), and thus extend the duration of post-operativeanalgesia provided by the ‘single shot’ caudal technique. Clonidine, an alpha 2agonist has extensively been used in neuraxial blocks(S et al., 1994) and peripheral nerve blocks to prolong theaction of bupivacaine. Dexmedetomidine is a useful non-opioid drug used to manage pain and sedation.

PRIMARYOBJECTIVES:

Tocompare caudal epidural bupivacaine with clonidine and bupivacaine withdexmedetomidine regarding the duration of analgesia in pediatric pts. postedfor infraumbilical surgeries under GA.

SECONDARYOBJECTIVES:

Toassess the synergistic effect and safety of adding dexmedetomidine tobupivacaine compared with clonidine to bupivacaine in caudal block ininfraumbilical surgeries.

Tocompare the haemodynamic changes during intraoperative and postoperativeperiod.

Tocompare the quality and duration of postoperative analgesia.

Tocompare the total amount of rescue analgesics used during the 12 hour postoperative period.

Tostudy the side effects and complications during the post operative period.

METHODOLOGY: Patients for the study will be conducted on 50 patients fulfilling the inclusion criteria. Patients will be randomly allocated into 2 study groups who will be administered with the following combination of drugs.

Group B will receive bupivacaine.25%(1ml/kg) andGroup C will receive bupivacaine .25%(1ml/k) with clonidine 1 µ/kg in normalsaline 1 ml**.**

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Pediatric patients from 2 yrs to 6 years.
  • ASA grade I-II 3.
  • Pediatric patients undergoing infraumbilical surgeries like hernia repair, circumcisions, orchidopexy, etc.
Exclusion Criteria
  • 1.Children less than 2 yrs or more than 6 yrs.
  • 2.ASA grade III –IV.
  • 3.Known allergy to any of the study drugs.
  • 4.Pre-operative hepatic or renal dysfunction.
  • 5.Serious cardiac or respiratory disease.
  • 6.History of developmental delay or mental retardation.
  • 7.Known or suspected coagulopathy.
  • 8.Signs of infection at the site of the proposed caudal block.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare caudal epidural bupivacaine with clonidine & bupivacaine with dexmedetomidine regarding the duration of analgesia in pediatric patients posted for infraumbilical surgeries under general anesthesia12 hours
Secondary Outcome Measures
NameTimeMethod
To assess the synergistic effect & safety of adding dexmedetomidine to bupivacaine compared with clonidine to bupivacaine in caudal block in infraumbilical surgeries.To compare the haemodynamic changes during intraoperative and postoperative period.

Trial Locations

Locations (1)

Acharya Vinobha Bhave Rural Hospital

🇮🇳

Wardha, MAHARASHTRA, India

Acharya Vinobha Bhave Rural Hospital
🇮🇳Wardha, MAHARASHTRA, India
Dr Shubham Rahane
Principal investigator
9359691943
shubhamrahane7@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.